These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12271658)

  • 1. Vinyl fluoride as an isoelectronic replacement for an enolate anion: inhibition of type II dehydroquinases.
    Frederickson M; Coggins JR; Abell C
    Chem Commun (Camb); 2002 Sep; (17):1886-7. PubMed ID: 12271658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design, synthesis, and evaluation of nanomolar type II dehydroquinase inhibitors.
    Payne RJ; Peyrot F; Kerbarh O; Abell AD; Abell C
    ChemMedChem; 2007 Jul; 2(7):1015-29. PubMed ID: 17487900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and evaluation of bifunctional inhibitors of type II dehydroquinase.
    Toscano MD; Frederickson M; Evans DP; Coggins JR; Abell C; González-Bello C
    Org Biomol Chem; 2003 Jun; 1(12):2075-83. PubMed ID: 12945898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible inhibition of type I dehydroquinase by substrates for type II dehydroquinase.
    Bello CG; Harris JM; Manthey MK; Coggins JR; Abell C
    Bioorg Med Chem Lett; 2000 Mar; 10(5):407-9. PubMed ID: 10743936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (1R,4S,5R)-3-Fluoro-1,4,5-trihydroxy-2-cyclohexene-1-carboxylic acid: the fluoro analogue of the enolate intermediate in the reaction catalyzed by type II dehydroquinases.
    Frederickson M; Roszak AW; Coggins JR; Lapthorn AJ; Abell C
    Org Biomol Chem; 2004 Jun; 2(11):1592-6. PubMed ID: 15162210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-substituted-3-dehydroquinic acids as potent competitive inhibitors of type II dehydroquinase.
    Prazeres VF; Castedo L; Lamb H; Hawkins AR; González-Bello C
    ChemMedChem; 2009 Dec; 4(12):1980-4. PubMed ID: 19856378
    [No Abstract]   [Full Text] [Related]  

  • 7. Understanding the key factors that control the inhibition of type II dehydroquinase by (2R)-2-benzyl-3-dehydroquinic acids.
    Peón A; Otero JM; Tizón L; Prazeres VF; Llamas-Saiz AL; Fox GC; van Raaij MJ; Lamb H; Hawkins AR; Gago F; Castedo L; González-Bello C
    ChemMedChem; 2010 Oct; 5(10):1726-33. PubMed ID: 20815012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic basis of the inhibition of type II dehydroquinase by (2S)- and (2R)-2-benzyl-3-dehydroquinic acids.
    Lence E; Tizón L; Otero JM; Peón A; Prazeres VF; Llamas-Saiz AL; Fox GC; van Raaij MJ; Lamb H; Hawkins AR; González-Bello C
    ACS Chem Biol; 2013 Mar; 8(3):568-77. PubMed ID: 23198883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural investigation of inhibitor designs targeting 3-dehydroquinate dehydratase from the shikimate pathway of Mycobacterium tuberculosis.
    Dias MV; Snee WC; Bromfield KM; Payne RJ; Palaninathan SK; Ciulli A; Howard NI; Abell C; Sacchettini JC; Blundell TL
    Biochem J; 2011 Jun; 436(3):729-39. PubMed ID: 21410435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structures of Helicobacter pylori type II dehydroquinase inhibitor complexes: new directions for inhibitor design.
    Robinson DA; Stewart KA; Price NC; Chalk PA; Coggins JR; Lapthorn AJ
    J Med Chem; 2006 Feb; 49(4):1282-90. PubMed ID: 16480265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomolar inhibition of type II dehydroquinase based on the enolate reaction mechanism.
    Toscano MD; Payne RJ; Chiba A; Kerbarh O; Abell C
    ChemMedChem; 2007 Jan; 2(1):101-12. PubMed ID: 17068841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vinyl sulfonium as novel proteolytic enzyme inhibitor.
    Zhao G; Zhou ZS
    Bioorg Med Chem Lett; 2001 Sep; 11(17):2331-5. PubMed ID: 11527725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type II Anion Relay Chemistry: Conformational Constraints To Achieve Effective [1,5]-Vinyl Brook Rearrangements.
    Liu Q; Chen Y; Zhang X; Houk KN; Liang Y; Smith AB
    J Am Chem Soc; 2017 Jun; 139(25):8710-8717. PubMed ID: 28613847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vinyl fluoride as a mimic of the "intermediate' enol form in the 5 alpha-reductase transformation: synthesis and in vitro activity of (N-1',1'-dimethylethyl)-3-haloandrost-3,5-diene-17 beta-carboxamides.
    Li X; Singh SM; Luu-The V; Côté J; Laplante S; Labrie F
    Bioorg Med Chem; 1996 Jan; 4(1):55-60. PubMed ID: 8689240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymic synthesis of 3-[3- 13C]dehydroquinic acid.
    Frederickson M; Parker EJ; Coggins JR; Abell C
    Org Biomol Chem; 2003 Oct; 1(19):3271-3. PubMed ID: 14584789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomolar competitive inhibitors of Mycobacterium tuberculosis and Streptomyces coelicolor type II dehydroquinase.
    Prazeres VF; Sánchez-Sixto C; Castedo L; Lamb H; Hawkins AR; Riboldi-Tunnicliffe A; Coggins JR; Lapthorn AJ; González-Bello C
    ChemMedChem; 2007 Feb; 2(2):194-207. PubMed ID: 17245805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of metabolic flux through the quinate pathway in Aspergillus nidulans.
    Wheeler KA; Lamb HK; Hawkins AR
    Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):195-205. PubMed ID: 8670107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design of new bifunctional inhibitors of type II dehydroquinase.
    Toscano MD; Stewart KA; Coggins JR; Lapthorn AJ; Abell C
    Org Biomol Chem; 2005 Sep; 3(17):3102-4. PubMed ID: 16106291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible overproduction of the Aspergillus nidulans pentafunctional AROM protein and the type-I and -II 3-dehydroquinases from Salmonella typhi and Mycobacterium tuberculosis.
    Moore JD; Lamb HK; Garbe T; Servos S; Dougan G; Charles IG; Hawkins AR
    Biochem J; 1992 Oct; 287 ( Pt 1)(Pt 1):173-81. PubMed ID: 1329726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthesis and biological activity of 2-[(substituted phenyl)vinyl] indole derivatives].
    Xu L; Xu SP
    Yao Xue Xue Bao; 2001 Feb; 36(2):100-4. PubMed ID: 12579873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.